CVS Health Stock – Fundamental Analysis

Price
90.39
10/14/2026
Oct 1996
Oct 2026

Fundamental Data & Ratios (Balance sheet update: 9/9/2026)

Balance Sheet Total Assets 261,064,000,000.00 ROE 28.81 %
Balance Sheet Total Equity 75,382,000,000.00 ROA 0.68 %
Cashflow Capital Expenditures -2,832,000,000.00 P/FCF 14.72
Cashflow Free Cash Flow 7,807,000,064.00 – –
Cashflow Operating Cash Flow 10,639,000,000.00 P/CF 10.80
Income Earnings per Share (diluted) 1.39 Div. Yield 2.94 %
Income Net Income 1,768,000,000.00 P/E 65.03
Income Shares Outstanding 1,283,000,000.00 P/B 1.53
Income Total Revenue 402,067,000,000.00 P/S 0.29

Ratios calculated on: 10/14/2026

Company Description

CVS Caremark Corporation (CVS Caremark), together with its subsidiaries, is a pharmacy health care provider in the United States. CVS Caremark provides pharmacy services through its pharmacy benefit management (PBM), mail order and specialty pharmacy division, CVS Caremark Pharmacy Services; approximately 7,300 CVS/pharmacy retail stores; retail-based health clinic subsidiary, MinuteClinic, and its online retail pharmacy, CVS.com. The Company operates in three business segments: Pharmacy Services, Retail Pharmacy and Corporate. Its corporate segment provides management and administrative services to support the overall operations of the Company. In April 2012, Health Net, Inc.'s subsidiary, Health Net Life Insurance Company, sold its Medicare stand-alone Prescription Drug Plan (Medicare PDP) business to a subsidiary of CVS Caremark. In February 2013, it bought Drogaria Onofre.

Advanced Analysis Features

Additional comparison and history views are available after login.

Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.cvshealth.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown. Learn more